Latest Diabetes: Type II news
GLP-1 Receptor Agonist Use Does Not Increase Insulin Discontinuation With Type 2 Diabetes
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonists Linked to Lower Mortality, Amputation Rate in PAD and Type 2 Diabetes
posted July 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Resistance Training Tied to Lower Type 2 Diabetes Risk
posted July 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Bofanglutide Linked to Meaningful Reductions in HbA1c in Adults With T2DM 
Poor Sleep Raises Liver Disease Risk in Adults With Type 2 Diabetes 
Resistance Training Linked to Lower CVD Risk in Women Related Articles
Oral Orforglipron Noninferior, Superior to Oral Semaglutide for T2DM 
Semaglutide May Increase Risk for Nonarteritic Anterior Ischemic Optic Neuropathy 
Maternal Diabetes Linked to Increased Risk for Epilepsy in Offspring 
Sodium-Glucose Cotransporter 2 Inhibitors Tied to Lower Use of Gout Medications Monthly Specialist Briefings
Stay Connected
